Answers are grounded in this paper and cite their sources.
Despite recent progress in treatment, prognostication for T-cell acute lymphoblastic leukemia (T-ALL) patients, including those with early T-cell precursor ALL (ETP-ALL), is rather poor [1]. Theref...
No takes yet. Share an insight, caveat, or question.
Dasgupta et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: